Home Chris Pryce

At the start of a new decade, it makes sense to look in the rear-view mirror to better understand where the industry is going. For drug plans, a crescendo of forecasts have predicted skyrocketing benefits costs, driven by high-cost drugs. That talk has only increased the cries for a national pharmacare strategy to make drugs more affordable. Looking back […]

  • January 16, 2020 November 12, 2020
  • 09:30

Although a national pharmacare strategy seems elusive, the Ontario government is making a fairly aggressive investment in that area by spending $465 million to boost its provincial drug coverage by covering residents under age 25 and from 65 onwards. The program, known as OHIP+, begins Jan. 1, 2018. Children and youth under age 25 will by automatically eligible […]

  • November 24, 2017 September 13, 2019
  • 10:45